The latest biopharma awards press releases and news


IMAPAC Applauds GC Biopharma on Winning Best Biologics CMO in South Korea Awards at the Asia Pacific Biologics CMO Excellence Awards 2023

Singapore, September 14, 2023 – IMAPAC, a leading event management company specializing in the biopharmaceutical industry, congratulates GC Biopharma on receiving the “Best Biologics CMO in South Korea” Awards at the 2023 Asia-Pacific Biologics CMO Excellence Awards ceremony. 

APBCEA 2023 acknowledges the exceptional achievements of top biologics companies and celebrates the innovation and leadership of industry trend-setters. Each year, APBCEA 2023 shortlists 5-7 nominees under each award category, and the final winners are determined by voting results from the bioprocessing community.

GC Biopharma is a top-tier biopharmaceutical company in South-Korea and has over 50 years of experience in development, production and exporting into 70 countries worldwide. As CMO, GC Biopharma provide premium Fill & Finish service to clinical and commercial customers for vaccines, recombinant and biosimilar pharmaceutical products. With 12 state-of-the-art filling lines in two brand-new manufacturing sites, GC Biopharma selling their owned 150 commercial products into over 70 countries.

GC Biopharma has a variety of priorities including: expanding domestic and international business, continued development of products etc. Beyond this, we have high hopes for our CMO business. Our mission is to become a leader in the global health industry, ushering in a healthier future for all humankind. I think that this APBCEA Awards we received will bolster our CMO business and make it stand out for its excellent CMO capability,” said Jason Lee, Head of CMO & External Manufacturing. 

“In addition to the existing freeze-drying filing line, our another new lyophilization (freeze-drying) filling line with isolator will be installed in Ochang which is GC’s main production hub, South Korea in the third quarter of 2024. With our remarkable CMO capability and history, we are going to continuously expand to achieve our mission to become a leader in the global health industry.


IMAPAC is a leading event management company specializing in the biopharmaceutical industry. With over 12 years of experience, IMAPAC has successfully organized more than 50 industry events, attracting over 15,000 participants from around the world. IMAPAC’s events are renowned for their high-quality content, prestigious speakers, and networking opportunities.


Jegan Sanska
[email protected]


IMAPAC has successfully held the Asia-Pacific Bioprocessing Excellence Awards 2023, recognizing outstanding achievements and contributions in bioprocessing. The awards ceremony attracted over 80 participants from more than 40 biopharmaceutical companies across the Asia-Pacific region, with 53 categories such as Best Biomanufacturing Team and Best Emerging Biotech Company.

The Biopharma Logistics and Supply Chain Excellence Awards (BLSA) 2023 APAC recognized outstanding achievements in biologistics across Asia at their 2023 ceremony, held alongside the 7th BioLogistics World Asia event. The awards celebrate exceptional personnel, organizations, and technologies in the industry and aim to inspire future innovators. 

The Biopharma R&D and Clinical Trials Awards (BRCTA) 2023 recognized exceptional Asian clinical trials leaders, organizations, and technologies over the past year. The awards include various categories such as Excellence Awards, Individual Awards, and Team Awards, identifying the best of the best in the industry.